Luminex Corporation is a company that develops, manufactures and sells Medical Instruments that could be an interesting play for investors. That is because, not only does the stock have decent short-term momentum, but it is seeing solid activity on the earnings estimate revision front as well.

These positive earnings estimate revisions suggest that analysts are becoming more optimistic on LMNX’s earnings for the coming quarter and year. In fact, consensus estimates have moved sharply higher for both of these time frames over the past four weeks, suggesting that Luminex could be a solid choice for investors.

Current Quarter Estimates for LMNX

In the past 30 days, 1 estimate has gone higher for Luminex, with no downward movement in the same time period. The trend has been pretty favorable too, with estimates increasing from 14 cents a share 30 days ago, to 18 cents today, a move of 28.6%. 

Current Year Estimates for LMNX

Meanwhile, Luminex’s current year figures are also looking quite promising, with 1 estimate moving higher in the past month, no downward movement in estimates. The consensus estimate trend has also seen a boost for this time frame, increasing from 65 cents per share 30 days ago to 81 cents  per share today, an increase of 24.6%. 

Bottom Line

The stock has also started to move higher lately, adding 6.5% over the past four weeks, suggesting that investors are starting to take note of this impressive story. So investors may definitely want to consider this Zacks Rank #2 (Buy) stock to profit in the near future.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>